Contract R&D and Manufacturing Organization-Speed up development & market launching by specialized CRMO Service

History

  • Company >
  • History
eubiologics
history
2010
~
Now
2019
  • 04Completion of the second plant (V Plant) in Chuncheon
2018
  • 12Start of construction work for the second plant in Chuncheon
  • 09Achievement of Euvichol-Plus® 10 million doses exports
2017
  • 12Technology Transfer Agreement of EcML (KIST)
  • 08Euvichol-Plus® prequalified (PQ) by WHO
  • 01KOSDAQ Listed
2016
  • 06Euvichol® signed the Long Term Agreement (LTA) with UNICEF.
2015
  • 12Euvichol® prequalified (PQ) by WHO.
  • 01Euvichol® export approved by MFDS in Korea.
2014
  • 09Additional API facilities for OCV (Euvichol®) installed.
  • 08Phase Three of clinical trial of OCV(Euvichol®) succeeded in the Philippines.
2013
  • 12IND approved for Phase Three of clinical trial of OCV(Euvichol®) in the Philippines.
2012
  • 07IND approved for Phase One of clinical trial of OCV(Euvichol®) in Korea.
  • 06Performed the technological development of the next-generation typhoid-fever vaccine (the Small and Medium Business Administration).
  • 03 Merged with EuBiopharm Co., Ltd.
  • 02Certified as a venture corporation.
2011
  • 02Performed a non-clinical trial of OCV(Euvichol).
2010
  • 12Performed the Tech. Transfer and a Feasibility Study.
  • 09Signed the contract of technology transfer for Oral Cholera Vaccine (OCV) with the International Vaccine Institute (IVI).
  • 03Founded EuBiologics Co., Ltd.